Scibetta James S

CIK 00013832424 companiesRIVER EDGE, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001383242

Recent Transactions

50 trades

Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2023-11-01+437,244→ 437,244 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2022-11-14+142,657→ 142,657 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2021-11-01+90,882→ 90,882 total
Other
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2021-06-19+4,800→ 625,958 total
Conversion
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2021-06-19+24,000→ 649,958 total
Conversion
Matinas BioPharma Holdings, Inc.$MTNB
Series B Preferred Stock
2021-06-19−12→ 0 total
Award
Aquestive Therapeutics, Inc.$AQST
Stock Option (Right to Purchase)
2021-06-15+20,000→ 20,000 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2020-11-02+122,605→ 122,605 total
Other
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2020-06-23+3,600→ 621,158 total
Award
Aquestive Therapeutics, Inc.$AQST
Stock Option (Right to Purchase)
2020-06-16+14,000→ 14,000 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2019-12-31+8,260→ 617,558 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2019-11-01+107,416→ 107,416 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2019-09-30+29,739→ 606,898 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-08-21$3.81/sh+900→ 31,635 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-08-20$3.80/sh+11,310→ 30,735 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-08-19$3.77/sh+10,761→ 19,425 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock
2019-06-30+21,879→ 577,159 total
Other
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2019-06-21+2,400→ 609,298 total
Award
Aquestive Therapeutics, Inc.$AQST
Stock Option (Right to Purchase)
2019-06-13+13,350→ 13,350 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock
2019-03-31+17,202→ 555,280 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock
2018-12-31+31,513→ 538,078 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2018-11-01+128,299→ 128,299 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2018-11-01+128,299→ 128,299 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock
2018-10-01+20,381→ 506,565 total
Award
Aquestive Therapeutics, Inc.$AQST
Stock Option (Right to Purchase)
2018-07-24+26,700→ 26,700 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock
2018-06-29+43,203→ 486,184 total
Purchase
Matinas BioPharma Holdings, Inc.$MTNB
Series B Convertible Preferred Stock
2018-06-21$1000.00/sh+12→ 12 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock
2018-03-30+24,672→ 442,981 total
Purchase
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock
2017-09-07$1.29/sh+5,000→ 418,309 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2017-06-05$43.32/sh−1,966→ 25,118 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2017-05-15$51.20/sh−20,000→ 27,084 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2017-05-15$5.49/sh+20,000→ 47,084 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2017-05-15−20,000→ 15,251 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2017-01-17$5.49/sh+17,627→ 47,084 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2017-01-17$38.97/sh−4,997→ 27,084 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2017-01-17$38.39/sh−15,003→ 32,081 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2017-01-17−2,373→ 0 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2017-01-17$1.61/sh+2,373→ 29,457 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2017-01-17−17,627→ 35,251 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2016-12-07+20,000→ 20,000 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2016-11-15$1.61/sh+20,000→ 47,084 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2016-11-15$36.50/sh−20,000→ 27,084 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2016-11-15−20,000→ 2,373 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2016-08-15−9,123→ 0 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2016-08-15−15,877→ 22,373 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2016-08-15$45.21/sh−25,000→ 27,084 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2016-08-15$1.61/sh+9,123→ 36,207 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2016-08-15$1.61/sh+15,877→ 52,084 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2016-06-15+32,500→ 32,500 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2016-06-15+16,250→ 26,754 total

Scibetta James S

Recent Transactions

Companies

Recent Filings

Address